Preisfindung im Rahmen des AMNOG-Verfahrens
Schnittstellenprobleme bei der Regulierung von Preisen für Arzneimittelinnovationen im Mehrebenensystem
Nomos, 1. Edition 2025, ca. 351 Pages
The product is part of the series
Bochumer Schriften zum Sozial- und Gesundheitsrecht
Book
ca.
€114.00
Published ca. July 2025 (can be pre-ordered)
ISBN
978-3-7560-3128-3
Description
The system of competitive pricing through supply and demand does not provide an equitable solution for pricing on drugs which are market exclusive due to patent-protection. The AMNOG-regulation procedure has been regulating the reimbursementss for patented, and as such, market-exclusive, drugs since 2011. The AMNOG procedure determines pricing based on findings from the regulatory approval procedure and shapes the economics of individual prescriptions. However, personalized gene therapies, whose benefits is only scientifically provable within limits, yet are high in price, exemplify, that the AMNOG procedure is increasinly reaching its limits in these interface issues. This thesis analyzes these interface problems and ends with a regulatory proposal.
Bibliographical data
| Edition | 1 |
|---|---|
| ISBN | 978-3-7560-3128-3 |
| Subtitle | Schnittstellenprobleme bei der Regulierung von Preisen für Arzneimittelinnovationen im Mehrebenensystem |
| Publication Date | ca. Jul 1, 2025 |
| Year of Publication | 2025 |
| Publisher | Nomos |
| Format | Softcover |
| Language | deutsch |
| Pages | ca. 351 |
| Medium | Book |
| Product Type | Scientific literature |
Additional material
Product safety information
Manufacturer of products offered under GPSR
Nomos Verlagsgesellschaft mbH & Co. KG
Waldseestraße 3 - 5
76530 Baden-Baden, Germany
service@nomos.de
www.nomos.de